A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells

Sarah K. Knutson(Epizyme (United States)), Tim J. Wigle(Epizyme (United States)), Natalie M. Warholic(Epizyme (United States)), Christopher J. Sneeringer(Epizyme (United States)), Christina J. Allain(Epizyme (United States)), Christine R. Klaus(Epizyme (United States)), Joelle D. Sacks(Epizyme (United States)), Alejandra Raimondi(Epizyme (United States)), Christina R. Majer(Epizyme (United States)), Jeffrey Song(Epizyme (United States)), Margaret Porter Scott(Epizyme (United States)), Lei Jin(Epizyme (United States)), J. Joshua Smith(Epizyme (United States)), Edward J. Olhava(Epizyme (United States)), Richard Chesworth(Epizyme (United States)), Mikel P. Moyer(Epizyme (United States)), Victoria M. Richon(Epizyme (United States)), Robert A. Copeland(Epizyme (United States)), Heike Keilhack(Epizyme (United States)), Roy M. Pollock(Epizyme (United States)), Kevin W. Kuntz(Epizyme (United States))
Nature Chemical Biology
September 30, 2012
Cited by 758

Abstract


Related Papers

No related papers found

Powered by citation graph analysis